Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.34 |
| ▸ | FEN1 | P39748 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.32 |
| ▸ | RARB | P10826 | 3/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.30 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17719460 | 0.94 | RARB (0.36) | ALOX5APFEN1GRM2S1PR1S1PR3 | |
| SCHEMBL20202949 | 0.94 | GRM2 (0.33) | ALOX5APFEN1GRM2 | |
| SCHEMBL20202969 | 0.93 | RARB (0.39) | ALOX5APFEN1GRM2S1PR1S1PR3 | |
| SCHEMBL20202968 | 0.93 | ALOX5AP (0.35) | ALOX5APFEN1GRM2 | |
| SCHEMBL20202970 | 0.93 | RARB (0.31) | RARBRARARARG | |
| SCHEMBL17083187 | 0.93 | RARB (0.31) | RARBRARARARG | |
| SCHEMBL17075778 | 0.91 | ALOX5AP (0.34) | ALOX5APFEN1GRM2 | |
| SCHEMBL20202931 | 0.89 | ALOX5AP (0.38) | ALOX5APFEN1GRM2S1PR1S1PR3 | |
| SCHEMBL20202966 | 0.89 | ALOX5AP (0.34) | ALOX5APFEN1GRM2 | |
| SCHEMBL1813180 | 0.89 | GRM2 (0.37) | ALOX5APFEN1GRM2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180148647-A1 | COMPOSITION AND LIQUID CRYSTAL DISPLAY USING SAME | DIC CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| EP-2977428-B1 | POLYMERIZABLE COMPOUND-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DAINIPPON INK & CHEMICALS (JP) | 2018-05-02 | — | — | EP | disclosed |
| US-9725651-B2 | Polymerizable compound-containing liquid crystal composition and liquid crystal display element using same | DIC CORPORATION (JP) | 2017-08-08 | — | — | US | disclosed |
| US-9725651-B2 | Polymerizable compound-containing liquid crystal composition and liquid crystal display element using same | DIC CORPORATION (JP) | 2017-08-08 | — | — | US | disclosed |
| US-20160122650-A1 | POLYMERIZABLE COMPOUND-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20160122650-A1 | POLYMERIZABLE COMPOUND-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-9315727-B2 | Compound having fluorinated naphthalene structure and liquid crystal composition of the same | DIC Corporation (Tokyo) (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20150259599-A1 | COMPOUND HAVING FLUORINATED NAPHTHALENE STRUCTURE AND LIQUID CRYSTAL COMPOSITION OF THE SAME | DIC CORPORATION (JP) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259599-A1 | COMPOUND HAVING FLUORINATED NAPHTHALENE STRUCTURE AND LIQUID CRYSTAL COMPOSITION OF THE SAME | TNK1, CTNND1, FLI1 | ALOX5AP 3554/4885FEN1 564/4885GRM2 3681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.